AAAAAA

   
Results: 1-25 | 26-50 | 51-55 |
Results: 51-55/55
Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells
Authors: Jego, G Robillard, N Puthier, D Amiot, M Accard, F Pineau, D Harousseau, JL Bataille, R Pellat-Deceunynck, C
Citation: G. Jego et al., Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells, BLOOD, 94(2), 1999, pp. 701-712
Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization
Authors: Li, JY Gaillard, F Moreau, A Harousseau, JL Laboisse, C Milpied, N Bataille, R Avet-Loiseau, H
Citation: Jy. Li et al., Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization, AM J PATH, 154(5), 1999, pp. 1449-1452
The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
Authors: Pellat-Deceunynck, C Barille, S Jego, G Puthier, D Robillard, N Pineau, D Rapp, MJ Harousseau, JL Amiot, M Bataille, R
Citation: C. Pellat-deceunynck et al., The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma, LEUKEMIA, 12(12), 1998, pp. 1977-1982
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) inpatients with plasma cell malignancies
Authors: Avet-Loiseau, H Li, JY Facon, T Brigaudeau, C Morineau, N Maloisel, F Rapp, MJ Talmant, P Trimoreau, F Jaccard, A Harousseau, JL Bataille, R
Citation: H. Avet-loiseau et al., High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) inpatients with plasma cell malignancies, CANCER RES, 58(24), 1998, pp. 5640-5645
Methods for evaluating biological response modifiers
Authors: Harousseau, JL
Citation: Jl. Harousseau, Methods for evaluating biological response modifiers, B CANCER, 85(12), 1998, pp. 993-996
Risultati: 1-25 | 26-50 | 51-55 |